Hi Subscriber,

BISU, Their deal in the CONGO could make BISU a huge winner in your portfolio, SOMETHING BIG IS COMING – TIME TO BUY

BISU is sitting @ .80 and is up 35% since our initial alert.  The stock has been consolidating @ the .80 level.  PSC think BISU could come alive and make you some BIG MONEY in the next five to ten times.

BISU’s GREENEX PRODUCT SAVES LIVES.  THIS PRODUCT MAKES BISU A WORLD LEADER IN THE FIGHT AGAINST MALARIA.

-                  As there is no vaccine available for protection against malaria despite decades of research, there is a need for an alternative method that offers a fairly reliable protection against malaria and Greenex is the answer!

-                  Due to conflicts and wars, migrations, deteriorating health systems, poverty, the parasites resistance to drugs and insecticides, global warming and many other events make malaria  extremely difficult to control and sustain

-                  Greenex will be tested in the next three months in Congo to finalize regulatory approval.  This will be the last step prior to final negotiation of a supply agreement in the next three to six months. Health experts estimate that each child under five years of age in Congo has 6 to 10 attacks of malaria per year. This is equivalent to as many as 100 million episodes, or even more, annually. Approximately 180,000 Congolese children under five die from the disease every year, and many others are orphaned when malaria weakens and kills their parents.

MEMBERS NEED TO RE-READ THIS PR.  BISU IS ABOUT TO GO KABOOM.

Bio-Solutions Corp. Announces a Mission to Africa to Perform a Pilot Trial of GreenEx(TM)

2009-11-17 08:34 ET – News Release

MONTREAL, QUEBEC — (MARKET WIRE) — 11/17/09

Bio-Solutions Corp. (OTCBB: BISU), announces a mission to perform a pilot trial for its main product GreenEx(TM) in a highly infested site within one of the targeted countries.

In its growth framework and discussion with three African Countries, Bio-Solutions Corp. accomplishes a second and important step, i.e. a first pilot trial design to show on site efficiency of GreenEx(TM) in December, 2009. "We are proud to have the opportunity to show the effectiveness of our product so quickly after its regulatory approval by the health authorities of this West African country. Bio-Solutions Corp’s Team will travel to the West African Country to evaluate the environmental condition in order to develop the perfect spreading strategy to assure the success of this experiment. This will be the final step prior to a commercial supply agreement," declares Dr Chaumillon.

Bio-Solutions Corp commercial strategy and turnkey operation approach seems to be the answer to the field problematic of the malaria infested countries. "In less than 6 months we have registered our product with the regulatory and conformity authorities. Now we are offered the possibility to demonstrate the efficiency of the GreenEx(TM) product directly under scrutiny of ministry of health experts." stressed Dr Chaumillon. Trial design and experiment will be completed in the next 60 days before starting the last phase; i.e. supply agreement negotiation.

For more information on Bio-Solutions Corp. and its products, please visit the company’s website at www.bio-solutionscorp.com

Contacts:
Adrian McKenzie
Investor & Public Relations
561-654-5722
pbdcllc@gmail.com
   

Please remember to do your due diligence on BISU.

We have not been compensated for this profile.

For more information on BISU,  please join us @ www.pennystockchaser.com.